Tau alternative splicing and frontotemporal dementia

Amar Kar, David Kuo, Rongqiao He, Jiawei Zhou, Jane Y. Wu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


A number of neurodegenerative diseases are characterized by the presence of abundant deposits containing Tau protein. Expression of the human tau gene is under complex regulation. Mutations in the tau gene have been identified in patients with frontotemporal lobe dementia. These mutations affect either biochemical/biophysical properties or the delicate balance of different splicing isoforms. In this review, we summarize recent advances in our understanding of genetics and molecular pathogenesis of tauopathies with the focus on frontotemporal lobe dementia. We review published studies on tau pre-mRNA splicing regulation. Understanding molecular mechanisms of tauopathies may help in developing effective therapies for neurodegenerative tauopathies and related disorders, including Alzheimer disease.

Original languageEnglish (US)
Pages (from-to)S29-S36
JournalAlzheimer Disease and Associated Disorders
Issue numberSUPPL. 1
StatePublished - Oct 2005


  • Frontotemporal dementia
  • Tau alternative splicing

ASJC Scopus subject areas

  • Clinical Psychology
  • Gerontology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health


Dive into the research topics of 'Tau alternative splicing and frontotemporal dementia'. Together they form a unique fingerprint.

Cite this